Seminars in Diagnostic Pathology

Papers
(The TQCC of Seminars in Diagnostic Pathology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Recent updates in thoracic SMARCA4-deficient undifferentiated tumor48
Artificial intelligence and machine learning overview in pathology & laboratory medicine: A general review of data preprocessing and basic supervised concepts47
SWI/SNF complex-deficient soft tissue neoplasms: An update46
AI in Pathology: What could possibly go wrong?32
HER2-low breast cancers: Current insights and future directions26
Update on prognostic and predictive biomarkers of breast cancer25
SWI/SNF-deficient head and neck neoplasms: An overview25
Artificial intelligence for dermatopathology: Current trends and the road ahead20
SWI/SNF-deficient thoraco-pulmonary neoplasms20
Immunohistochemistry in melanocytic lesions: Updates with a practical review for pathologists20
Spleen: Development, anatomy and reactive lymphoid proliferations19
Histopathologic diagnosis of endometrial precancers: Updates and future directions19
SWI/SNF-deficient malignancies of the female genital tract16
Molecular events in the pathogenesis of vulvar squamous cell carcinoma16
Acute mediastinitis, mediastinal granuloma, and chronic fibrosing mediastinitis: A review15
A review of prognostic factors in squamous cell carcinoma of the vulva: Evidence from the last decade15
Recent updates in salivary gland tumors of the lung14
SWI/SNF deficient central nervous system neoplasms14
Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach14
Immunohistochemistry for the diagnosis of renal epithelial neoplasms13
Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors13
Updates in the molecular pathology of non-small cell lung cancer13
Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit12
Mesenchymal lesions of the vulva12
Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathology12
From the ashes of “Ewing-like” sarcoma: A contemporary update of the classification, immunohistochemistry, and molecular genetics of round cell sarcomas12
Advances in cytology of lung cancer11
T-cell and NK-cell lymphomas in the lung11
Practical immunohistochemistry in the classification of salivary gland neoplasms11
NUT carcinoma of the lung11
Primary adenocarcinomas of the vulva and related structures: An enigmatic and diverse group of tumors✰11
Pediatric vulvar malignancies: rare but important to know10
Ciliated muconodular papillary tumor/bronchiolar adenoma of the lung10
The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary✰10
Deep learning in digital pathology for personalized treatment plans of cancer patients10
High-grade endometrial carcinomas: Morphologic spectrum and molecular classification10
Molecular landscape of thymic epithelial tumors10
Germ cell neoplasms of the testis: Update for 202210
Putative precancerous lesions of vulvar squamous cell carcinoma8
Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features8
Rare EBV-associated B cell neoplasms of the gastrointestinal tract8
Primary Pulmonary B-cell Lymphoma8
Recent advances and current controversies in lung neuroendocrine neoplasms✰8
Extramammary Paget disease of the vulva8
Endometrial stromal tumors: Diagnostic updates and challenges8
Vascular neoplasms and non-neoplastic vascular lesions of the spleen8
SWI/SNF-deficient neoplasms of the genitourinary tract7
Thymoma: Histologically a heterogenous group of tumors7
The thymus: General concepts on embryology, anatomy, histology and immunohistochemistry.7
Artificial intelligence in clinical multiparameter flow cytometry and mass cytometry–key tools and progress7
Gestational trophoblastic disease- rare, sometimes dramatic, and what we know so far7
Lichenoid dermatoses involving the vulva: A clinical-pathologic correlation✰7
Dedifferentiated and undifferentiated neoplasms: A conceptual approach7
Mimickers of pulmonary lymphoma6
Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis6
Germ Cell Tumors of the Ovary: A Review6
Update on sentinel node pathology in breast cancer6
Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts6
SWI/SNF-deficient cancers of the Gastroenteropancreatic tract: an in-depth review of the literature and pathology6
Primary mediastinal germ cell tumors6
Updates in molecular genetics of acute myeloid leukemia6
Multilocular thymic cyst (MTC) and other tumors with MTC features: Pitfalls in diagnosis5
Diagnosis of soft tissue tumors using immunohistochemistry as a surrogate for recurrent fusion oncoproteins5
Papillary lesions of the breast – review and practical issues5
Navigating through perplex morphologic changes after exogenous hormone usage5
Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques5
Aggressive Mediastinal Lymphomas5
Undifferentiated and dedifferentiated head and neck carcinomas5
Undifferentiated and dedifferentiated neoplasms of the female genital tract5
Emerging molecular subtypes and therapies in acute lymphoblastic leukemia5
Myeloid diseases in the lung and pleura5
Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract4
Fibroepithelial lesions of the breast: A review of recurring diagnostic issues4
The current practice of telecytology for rapid on-site evaluation (ROSE): Practical considerations and limitations4
Overview of Gastrointestinal Lymphoproliferative disorders✰4
Preface: Artificial intelligence (AI), machine learning ML) and digital pathology integration are the next major chapter in our diagnostic pathology and laboratory medicine arena4
Pleomorphic (giant cell) carcinoma revisited: A historical perspective and conceptual reappraisal4
Contemporary diagnostic approach to atypical vascular lesion and angiosarcoma4
Challenges and pitfalls in the diagnosis of IgG4-related disease4
Non-hematopoietic neoplastic and pseudoneoplastic lesions of the spleen4
B-cell neoplasms and Hodgkin lymphoma in the spleen4
0.085636854171753